1-9 of 9
Salli Fennessey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results of a Phase II Study

Shayna Sarosiek, John Mark Sloan, MD, Karen Quillen, MDMPH, Dina Brauneis, ANP, Ramon Cruz, Amanda Schulman, Salli Fennessey, Anthony Shelton, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4578.
https://doi.org/10.1182/blood-2019-129095
Published: 2019
Journal Articles

Safety, Tolerability and Response Rates of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Results of a Phase II Study

Vaishali Sanchorawala, MD, Shayna Sarosiek, MD, John Mark Sloan, MD, Dina Brauneis, NP, Mary Ellen Migre, Meredith Mistark, Stephanie Santos, Ramon Cruz, Salli Fennessey, Anthony C Shelton, RN
Journal: Blood
Blood (2018) 132 (Supplement 1): 2005.
https://doi.org/10.1182/blood-2018-99-112991
Published: 2018
Journal Articles

Safety and Tolerability of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Preliminary Results of a Phase II Study

Vaishali Sanchorawala, MD, Shayna Sarosiek, MD, John Mark Sloan, MD, Dina Brauneis, NP, Mary Ellen Migre, Meredith Mistark, Stephanie Santos, Salli Fennessey, Anthony C Shelton, RN
Journal: Blood
Blood (2017) 130 (Supplement 1): 507.
https://doi.org/10.1182/blood.V130.Suppl_1.507.507
Published: 2017
Journal Articles

Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis

Umit Tapan, David C. Seldin, Kathleen T. Finn, Salli Fennessey, Anthony Shelton, Jerome B. Zeldis, Vaishali Sanchorawala
Journal: Blood
Blood (2010) 116 (23): 5071–5072.
https://doi.org/10.1182/blood-2010-09-305136
Published: 2010
Journal Articles

Increases In B-Type Natriuretic Peptide (BNP) During Treatment with Lenalidomide In AL Amyloidosis

Umit Tapan, MD, David C Seldin, MD, PhD, Kathleen T Finn, ANP, Salli Fennessey, CRA, Anthony C Shelton, RN, Jerome B. Zeldis, MD, PhD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2010) 116 (21): 3021.
https://doi.org/10.1182/blood.V116.21.3021.3021
Published: 2010
Journal Articles

Lenalidomide Treatment In Patients with AL Amyloidosis Associated End-Stage Renal Disease and Dialysis

Vaishali Sanchorawala, MD, Kathleen T Finn, ANP, Salli Fennessey, CRA, Anthony C Shelton, RN, Jerome B. Zeldis, MD, PhD, David C Seldin, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3022.
https://doi.org/10.1182/blood.V116.21.3022.3022
Published: 2010
Journal Articles

Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis

Vaishali Sanchorawala, Kathleen T. Finn, Salli Fennessey, Anthony Shelton, Gheorghe Doros, Jerome B. Zeldis, David C. Seldin
Journal: Blood
Blood (2010) 116 (11): 1990–1991.
https://doi.org/10.1182/blood-2010-07-295485
Published: 2010
Journal Articles

Durable Responses to Lenalidomide (Revlimid®) in Patients with AL Amyloidosis: Follow Up of a Phase II Trial.

David C. Seldin, MD, PhD, Michael Rosenzweig, MD, Kathleen T. Finn, RN, NP, Salli Fennessey, Anthony Shelton, Jerome B. Zeldis, MD, Martha Skinner, MD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2007) 110 (11): 192.
https://doi.org/10.1182/blood.V110.11.192.192
Published: 2007
Journal Articles

Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial

Clinical Trials & Observations
Vaishali Sanchorawala, Daniel G. Wright, Michael Rosenzweig, Kathleen T. Finn, Salli Fennessey, Jerome B. Zeldis, Martha Skinner, David C. Seldin
Journal: Blood
Blood (2006) 109 (2): 492–496.
https://doi.org/10.1182/blood-2006-07-030544
Published: 2006